文献速递烧伤创面修复

局部抗菌药物对烧伤创面细菌分离株的体外效力

Efficacy of Topical Antimicrobial Agents Against Bacterial Isolates From Burn Wounds.
PubMed 文献 · J Burn Care Res · 2020-01-01

结果显示,1:1:1+双抗生素和3:1+双抗生素复合制剂对100%的分离株有效,其他局部药物效果中等,提示需多种局部药物覆盖广谱微生物。

要点

  • 其他局部药物效果中等,需多种药物联合覆盖广谱微生物。

核心结论

  • 其他局部抗菌药物效果中等,提示需多种局部药物以达到广谱覆盖。
  • 局部抗菌药物耐药性的发展需进一步研究。

主要发现

  • 1:1:1+双抗生素(1份杆菌肽:1份磺胺嘧啶银:100,000单位/g制霉菌素+5 mg/g硫酸新霉素+500单位/g多粘菌素B)对100%分离株有效。
  • 3:1+双抗生素(3份杆菌肽:1份磺胺嘧啶银+5 mg/g硫酸新霉素+500单位/g多粘菌素B)对100%分离株有效。
  • 其他局部药物显示中等效力。

临床怎么用

  • 烧伤急性期可考虑使用1:1:1+双抗生素或3:1+双抗生素复合制剂以覆盖广谱微生物。
  • 需联合多种局部抗菌药物以达到广谱覆盖。

局限性

  • 局部抗菌药物耐药性的发展需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Topically applied antimicrobials are key to the prevention of infection and mortality in the acute burn population. The purpose of this study was to determine the in vitro effectiveness of commercially available topical antimicrobials, as well as topical preparations that were compounded in our burn care institution. One-hundred twenty microorganisms were tested against these topical antimicrobials and in vitro effectiveness was observed. Results showed that compounded preparations of 1:1:1 + Double Antibiotic (1 part bacitracin: 1 part silver sulfadiazine: 100,000 units/g nystatin + 5 mg/g neomycin sulfate + 500 units/g polymyxin B) and 3:1 + Double Antibiotic (3 part bacitracin: 1 part silver sulfadiazine + 5mg/g neomycin sulfate + 500 units/g polymyxin B) were effective against 100% of the isolates tested. Other topical agents showed moderate effectiveness, thus demonstrating the need for multiple topical agents to reach a broad spectrum of microorganisms. However, the development of topical antimicrobial resistance needs further study.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Nethery W, Warner P, Durkee P, et al. Efficacy of Topical Antimicrobial Agents Against Bacterial Isolates From Burn Wounds. J Burn Care Res. 2020. PMID: 32303755. doi:10.1093/jbcr/iraa048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。